Logo image of RVX.CA

RESVERLOGIX CORP (RVX.CA) Stock Price, Quote, News and Overview

TSX:RVX - Toronto Stock Exchange - CA76128M1086 - Common Stock - Currency: CAD

0.21  -0.02 (-6.67%)

RVX.CA Quote, Performance and Key Statistics

RESVERLOGIX CORP

TSX:RVX (7/23/2025, 7:00:00 PM)

0.21

-0.02 (-6.67%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.3
52 Week Low0.04
Market Cap59.71M
Shares284.31M
Float191.77M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO10-12 2001-10-12


RVX.CA short term performance overview.The bars show the price performance of RVX.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 100 200 300 400

RVX.CA long term performance overview.The bars show the price performance of RVX.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 100 200 300

The current stock price of RVX.CA is 0.21 CAD. In the past month the price increased by 425%. In the past year, price increased by 320%.

RESVERLOGIX CORP / RVX Daily stock chart

RVX.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRX.CA FENNEC PHARMACEUTICALS INC N/A 324.26M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 252.08M
EDT.CA SPECTRAL MEDICAL INC N/A 225.56M
TH.CA THERATECHNOLOGIES INC N/A 196.79M
ONC.CA ONCOLYTICS BIOTECH INC N/A 143.00M
WLLW.CA WILLOW BIOSCIENCES INC N/A 119.59M
HBP.CA HELIX BIOPHARMA CORP N/A 77.13M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 70.87M
COV.CA COVALON TECHNOLOGIES LTD 19.46 69.37M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 56.19M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 45.90M
MBX.CA MICROBIX BIOSYSTEMS INC 29.5 41.47M

About RVX.CA

Company Profile

RVX logo image Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. The company is headquartered in Calgary, Alberta and currently employs 18 full-time employees. The company went IPO on 2001-10-12. The firm is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The firm's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. The company partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

Company Info

RESVERLOGIX CORP

300-4820 Richard Rd SW

Calgary ALBERTA T3E 6L1 CA

CEO: Donald J. McCaffrey

Employees: 18

RVX Company Website

RVX Investor Relations

Phone: 14032549252

RESVERLOGIX CORP / RVX.CA FAQ

What is the stock price of RESVERLOGIX CORP today?

The current stock price of RVX.CA is 0.21 CAD. The price decreased by -6.67% in the last trading session.


What is the ticker symbol for RESVERLOGIX CORP stock?

The exchange symbol of RESVERLOGIX CORP is RVX and it is listed on the Toronto Stock Exchange exchange.


On which exchange is RVX.CA stock listed?

RVX.CA stock is listed on the Toronto Stock Exchange exchange.


What is RESVERLOGIX CORP worth?

RESVERLOGIX CORP (RVX.CA) has a market capitalization of 59.71M CAD. This makes RVX.CA a Micro Cap stock.


How many employees does RESVERLOGIX CORP have?

RESVERLOGIX CORP (RVX.CA) currently has 18 employees.


Should I buy RESVERLOGIX CORP (RVX.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RESVERLOGIX CORP (RVX.CA) stock pay dividends?

RVX.CA does not pay a dividend.


When does RESVERLOGIX CORP (RVX.CA) report earnings?

RESVERLOGIX CORP (RVX.CA) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of RESVERLOGIX CORP (RVX.CA)?

RESVERLOGIX CORP (RVX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).


RVX.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to RVX.CA. When comparing the yearly performance of all stocks, RVX.CA is one of the better performing stocks in the market, outperforming 99.4% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RVX.CA Financial Highlights

Over the last trailing twelve months RVX.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -30.39% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -181.84%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-690%
Sales Q2Q%N/A
EPS 1Y (TTM)-30.39%
Revenue 1Y (TTM)N/A

RVX.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to RVX.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.


Ownership
Inst OwnersN/A
Ins Owners2.56%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A